Affyimmune Therapeutics

Affyimmune Therapeutics company information, Employees & Contact Information

Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy. The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others.

Company Details

Employees
12
Founded
-
Address
22 Strathmore Rd, Natick,massachusetts 01760,united States
Phone
(617) 699-1965
Industry
Biotechnology
HQ
Natick, Massachusetts
Looking for a particular Affyimmune Therapeutics employee's phone or email?

Affyimmune Therapeutics Questions

News

AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer - PR Newswire

AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer PR Newswire

AffyImmune Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AIC100 in Recurrent Anaplastic Thyroid Cancer - Business Wire

AffyImmune Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AIC100 in Recurrent Anaplastic Thyroid Cancer Business Wire

AffyImmune hires former venture capital director as new leader, after first CEO departed in 4 months - Worcester Business Journal

AffyImmune hires former venture capital director as new leader, after first CEO departed in 4 months Worcester Business Journal

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s - Endpoints News

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s Endpoints News

AffyImmune attracts $30M with its CAR-T strategy for beleaguered solid tumor cancers - Fierce Biotech

AffyImmune attracts $30M with its CAR-T strategy for beleaguered solid tumor cancers Fierce Biotech

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC - BioSpace

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC BioSpace

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance - PR Newswire

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance PR Newswire

AffyImmune Appoints Drs. Rick Rutter and Jorge Nieva to Board of Directors - Business Wire

AffyImmune Appoints Drs. Rick Rutter and Jorge Nieva to Board of Directors Business Wire

AffyImmune Therapeutics Appoints Dr. Sonal Gupta as Senior Vice President - citybiz

AffyImmune Therapeutics Appoints Dr. Sonal Gupta as Senior Vice President citybiz

AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer - Business Wire

AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer Business Wire

Top Affyimmune Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant